Building a remediation plan for your trainees: A national qualitative study of pediatric residency program directors.

Monday, May 1, 2023

8:00 AM – 8:15 AM ET

Location: Convention Center: 202 A

Publication Number: 3100.1

Nicola Orlov, University of Chicago Division of the Biological Sciences The Pritzker School of Medicine, Chicago, IL, United States; Nathaniel Goodrich, University of Nebraska College of Medicine, Omaha, NE, United States; Elizabeth Nelsen, Upstate Golisano Children's Hospital, Syracuse, NY, United States; David Mills, Medical University of South Carolina, Mt. Pleasant, SC, United States; Su-Ting T. Li, University of California Davis, Sacramento, CA, United States

Presenting Author(s)

Nicola Orlov, MD MPH (she/her/hers)
Associate Professor of Pediatrics
University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
Chicago, Illinois, United States

Disclosure(s):

Nicola Orlov, MD MPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Nathaniel Goodrich, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Elizabeth Nelsen, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

David Mills, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Su-Ting T. Li, MD, MPH: Amgen (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Eli Lilly (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Johnson & Johnson (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Merck (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Organon (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); Proctor & Gamble (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)